What is the initial antiretroviral therapy (ART) regimen for pregnant women with HIV infection?

Updated: Jun 23, 2020
  • Author: Madhu Chhanda Choudhary, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


The preferred initial regimen in pregnancy is a backbone of dual nucleoside analogue reverse transcriptase inhibitors (NRTI) with either ritonavir-boosted protease inhibitor (PI) or an integrase Inhibitor.

Three-drug ART has reduced maternal-fetal HIV transmission rate to less than 2%. However, the safest and most efficacious combination is not yet clear. [6]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!